Peptilogics is a clinical-stage biotechnology company specializing in the design and development of innovative peptide therapeutics. By utilizing advanced technologies such as machine learning and automation, Peptilogics creates scalable platforms that integrate proprietary hardware, software, bioinformatics, chemistry, and molecular biology. This comprehensive approach supports various stages of drug development, from basic research and target validation to clinical trials, positioning Peptilogics as a leader in the biotechnology sector.